Doccla Virtual Wards

Doccla is a virtual care company registered in London (Doccla UK Limited, registered with the Care Quality Commission) with Swedish roots. It addresses hospital bed pressure by letting patients be monitored at home as virtual ward inpatients, and states it has monitored millions of patient days across 11 European countries.

The system combines a patient app, a clinician dashboard and a patient referral service, backed by clinical monitoring, patient support, compatible Bluetooth devices and device logistics. Data flows two ways with electronic health records. Customers are NHS trusts and integrated care boards, Irish and Welsh health services and private providers.

• Patient app: patients record vitals and symptoms at home, with Bluetooth transfer from compatible devices.
• Clinician dashboard: staff review alerts and trends for all virtual ward patients in one place.
• Patient referral service: hospitals and community teams refer eligible patients into the virtual ward.
• Clinical monitoring: a managed team supports proactive monitoring and patient support.
• Device logistics: devices are supplied to and collected from patients' homes.
• EHR integration: bidirectional data sharing with electronic health records.

A private hospital group in Vietnam could run a post-discharge virtual ward for heart failure and COPD patients. Large public hospitals could shorten stays after surgery with home vital-sign monitoring. Insurers could fund monitored home recovery for chronic disease cohorts.

Reported results on the site include 34% fewer non-elective admissions (BNSSG ICB, 2024) and GBP 3,900 saved per patient per year (LLR ICB, 2025). The company reports 95% patient satisfaction and an NPS of 75 (2025). Hospitals free inpatient beds while keeping clinical oversight through a managed monitoring service.

Health systems are moving acute and chronic care from wards to homes to relieve bed capacity, and virtual wards are a funded priority in the UK and Ireland. Vietnam and Southeast Asia face rising chronic disease and overcrowded tertiary hospitals, which makes remote monitoring models relevant for hospital networks.

Registered office in London; Swedish-founded per the company's press page. Funding: GBP 2.4m seed (2021), GBP 15m Series A (2022), GBP 35m Series B (2024). Acquired SaaS OTH in 2023. Partnered with Charite in Germany (2025).